Technical Analysis for STOK - Stoke Therapeutics, Inc.

Grade Last Price % Change Price Change
D 6.08 -4.85% -0.31
STOK closed down 4.85 percent on Monday, March 18, 2024, on 76 percent of normal volume. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Down

Date Alert Name Type % Chg
Fell Below 200 DMA Bearish 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New Downtrend Bearish -4.85%
200 DMA Support Bullish -4.85%
Wide Bands Range Expansion -4.85%
Fell Below 20 DMA Bearish -6.17%
Outside Day Range Expansion -6.17%

   Recent Intraday Alerts

Alert Time
200 DMA Support about 11 hours ago
Down 5% about 15 hours ago
Down 3% about 15 hours ago
Up 5% about 15 hours ago
Up 3% about 15 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Stoke Therapeutics is a biotechnology company that is pioneering a new way to treat the underlying causes of severe genetic diseases by precisely upregulating protein expression to restore target proteins to near normal levels. Stoke aims to develop the first precision medicine platform to target the underlying cause of a broad spectrum of genetic diseases in which the patient has one healthy copy of a gene and one mutated copy that fails to produce a protein essential to health. These diseases, in which loss of approximately 50 percent of normal protein expression causes disease, are called autosomal dominant haploinsufficiencies. Stoke was launched with investments by Apple Tree Partners. Stoke is headquartered in Bedford, Massachusetts with offices in Cambridge, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Disease Precision Medicine Genetic Diseases Proteins Epigenetics Severe Genetic Diseases

Is STOK a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 13.9999
52 Week Low 3.35
Average Volume 201,407
200-Day Moving Average 6.20
50-Day Moving Average 5.69
20-Day Moving Average 6.85
10-Day Moving Average 7.00
Average True Range 0.72
RSI (14) 46.24
ADX 23.94
+DI 17.07
-DI 19.80
Chandelier Exit (Long, 3 ATRs) 6.42
Chandelier Exit (Short, 3 ATRs) 7.08
Upper Bollinger Bands 8.61
Lower Bollinger Band 5.08
Percent B (%b) 0.28
BandWidth 51.55
MACD Line 0.28
MACD Signal Line 0.48
MACD Histogram -0.1995
Fundamentals Value
Market Cap 271.5 Million
Num Shares 44.7 Million
EPS -2.43
Price-to-Earnings (P/E) Ratio -2.50
Price-to-Sales 22.55
Price-to-Book 1.21
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.27
Resistance 3 (R3) 7.34 7.03 7.07
Resistance 2 (R2) 7.03 6.72 6.99 7.00
Resistance 1 (R1) 6.55 6.54 6.40 6.48 6.94
Pivot Point 6.24 6.24 6.16 6.20 6.24
Support 1 (S1) 5.76 5.93 5.61 5.69 5.22
Support 2 (S2) 5.45 5.75 5.41 5.16
Support 3 (S3) 4.97 5.45 5.09
Support 4 (S4) 4.90